Complimentary Wallchart: Guide to Hematopoietic Colonies Derived from Human Cord Blood Progenitors
Request your copy
Link
Most Common Brain Cancer May Originate in Neural Stem Cells
University of Michigan scientists have found that a deficiency in a key tumor suppressor gene in the brain leads to the most common type of adult brain cancer.
Article
Harnessing the Brain’s Own Ability for Repair
Neuroscientists at Sydney’s Garvan Institute of Medical Research have shown that nerve cells in the brain produce an anti-inflammatory molecule that allows the brain to repair itself.
Article
Researchers Link Pathway to Breast Cancer Stem Cells
The researchers found that several pathways linked to the gene, called PTEN, also affected the growth of breast cancer stem cells.
Article
Ottawa Scientists Discover New Way to Enhance Stem Cells to Stimulate Muscle Regeneration
Their research shows for the first time that a protein called Wnt7a increases the number of stem cells in muscle tissue, leading to accelerated growth and repair of skeletal muscle.
Article
Chinese Researchers Find Way to Make Pig Stem Cells
Researchers have found a way to transform ordinary cells from pigs into powerful stem cells in a move that may have implications for human health.
Article
Fruit Fly Stem Cells Filmed Live
Recently, asymmetric cell division was filmed in vivo in fruit fly germinal stem cells for the first time by researchers.
Article
ABSTRACTS, REVIEWS AND SPECIAL REPORTS
Generation of Human Induced Pluripotent Stem Cells by Direct Delivery of Reprogramming Proteins
This study reports the generation of stable iPSCs from human fibroblasts by directly delivering four reprogramming proteins (Oct4, Sox2, Klf4, and c-Myc) fused with a cell-penetrating peptide. (Cell Stem Cell)
Article
Metastable Pluripotent States in NOD-Mouse-Derived ESCs
Here the researchers characterize pluripotent states in the non-obese diabetic mouse strain, which prior to this study was considered non-permissive for ESC derivation. (Cell Stem Cell)
Article
Elsevier Tweaks Custom Pub Rules
Publishing company Elsevier is revising its policies and procedures for partnering with pharmaceutical companies to create custom publications in response to recent media attention over a fake journal created by the company and paid for by Merck.
Article
Visit our events page to stay up to date with the latest events in the cell, gene and immunotherapy community.
Recruit Top Talent
Reach more than 11,000 potential candidates by posting your organization’s career opportunities with Cell Therapy News.
Visit here to post your career opportunities.